<i>TSC2</i>-Mutant Yucatan Minipig Cardiac Rhabdomyoma Model Reveals mTORC1 Activation and MITF/TFE Expression Signature

Elias Bou Farhat; Heng Du; Chrystalle Katte Carreon; Jad Halawi; Sophie Kudler; Magdalena Losko; Zachary T. Herbert; Adrienne L. Watson; Daniel Carlson; Dennis A. Webster; Derek M. Korpela; David M. Meredith; Elizabeth P. Henske; David J. Kwiatkowski

doi:10.1172/jci.insight.211025

TSC2-Mutant Yucatan Minipig Cardiac Rhabdomyoma Model Reveals mTORC1 Activation and MITF/TFE Expression Signature

Elias Bou Farhat,¹ Heng Du,¹ Chrystalle Katte Carreon,² Jad Halawi,¹ Sophie Kudler,¹ Magdalena Losko,¹ Zachary T. Herbert,³ Adrienne L. Watson,⁴ Daniel Carlson,⁵ Dennis A. Webster,⁵ Derek M. Korpela,⁵ David M. Meredith,⁶ Elizabeth P. Henske,¹ and David J. Kwiatkowski¹

Published November 5, 2026 - More info

View PDF

Abstract

Tuberous sclerosis complex (TSC) is an inherited tumor predisposition syndrome caused by pathogenic variants in TSC1 or TSC2, yet no animal model faithfully recapitulates the cardiac rhabdomyomas (CR) that are among its earliest manifestations. We generated a heterozygous TSC2-mutant Yucatan minipig carrying the recurrent pathogenic TSC2 p.Arg505* variant and characterized its cardiac phenotype using histopathology, immunohistochemistry, and RNA sequencing. TSC2-mutant minipigs consistently developed multiple CR that closely resembled human lesions, including enlarged glycogen-rich spider cells and activation of mechanistic target of rapamycin complex 1 (mTORC1) signaling. Comparative transcriptomic analyses demonstrated enrichment of a conserved TSC-associated gene expression program and activation of microphthalmia/transcription factor E (MITF/TFE)-regulated lysosomal pathways in both human and minipig tumors. Although other manifestations of TSC were not observed during the first year of life, this large-animal model faithfully reproduced the principal histopathologic and molecular features of human CR. These findings have established the TSC2-mutant Yucatan minipig as what we believe to be the first large-animal model of TSC-associated CR and provide a physiologically relevant platform for investigating tumor pathogenesis, mechanisms of spontaneous regression, and therapeutic strategies targeting mTORC1- and MITF/TFE-dependent signaling.

TSC2-Mutant Yucatan Minipig Cardiac Rhabdomyoma Model Reveals mTORC1 Activation and MITF/TFE Expression Signature

Elias Bou Farhat,¹ Heng Du,¹ Chrystalle Katte Carreon,² Jad Halawi,¹ Sophie Kudler,¹ Magdalena Losko,¹ Zachary T. Herbert,³ Adrienne L. Watson,⁴ Daniel Carlson,⁵ Dennis A. Webster,⁵ Derek M. Korpela,⁵ David M. Meredith,⁶ Elizabeth P. Henske,¹ and David J. Kwiatkowski¹

Article tools

Metrics

Go to

TSC2-Mutant Yucatan Minipig Cardiac Rhabdomyoma Model Reveals mTORC1 Activation and MITF/TFE Expression Signature

Elias Bou Farhat,1 Heng Du,1 Chrystalle Katte Carreon,2 Jad Halawi,1 Sophie Kudler,1 Magdalena Losko,1 Zachary T. Herbert,3 Adrienne L. Watson,4 Daniel Carlson,5 Dennis A. Webster,5 Derek M. Korpela,5 David M. Meredith,6 Elizabeth P. Henske,1 and David J. Kwiatkowski1

Article tools

Metrics

Go to

Sign up for email alerts

Elias Bou Farhat,¹ Heng Du,¹ Chrystalle Katte Carreon,² Jad Halawi,¹ Sophie Kudler,¹ Magdalena Losko,¹ Zachary T. Herbert,³ Adrienne L. Watson,⁴ Daniel Carlson,⁵ Dennis A. Webster,⁵ Derek M. Korpela,⁵ David M. Meredith,⁶ Elizabeth P. Henske,¹ and David J. Kwiatkowski¹